Pooled prevalence of three major cardiovascular risk factors in patients undergoing left main bifurcation stenting: a

Gianluca Rigatelli1, Marco Zuin2, Dobrin Vassilev3

  • 1Section of Cardiovascular Diagnosis and Endoluminal Interventions, Rovigo General Hospital, Rovigo, Italy - jackyheart@libero.it.

Insights

Major cardiovascular risk factors like hypertension, hyperlipidemia, and diabetes are common in Left Main bifurcation disease patients. Hypertension is most prevalent in severe cases requiring two-stent procedures.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Public Health

Background:

  • Left Main (LM) bifurcation disease is a critical condition.
  • Prevalence of major cardiovascular risk factors in LM bifurcation disease patients is not well-established.
  • Understanding these risk factors is crucial for developing computational models.

Purpose of the Study:

  • To systematically review and meta-analyze the prevalence of three major cardiovascular risk factors (hypertension, hyperlipidemia, diabetes mellitus) in patients treated for LM bifurcation disease.
  • To compare the prevalence of these risk factors between single-stent and two-stent strategies.

Main Methods:

  • Systematic review and meta-analysis adhering to PRISMA guidelines.
  • Searched Cochrane Library, Embase, PubMed, and Google Scholar for studies published between January 2015 and October 2020.
  • Included studies comparing single- versus two-stent strategies for LM bifurcation disease and reporting prevalence of hypertension (HT), hyperlipidemia (HyperL), and diabetes mellitus (DM).

Main Results:

  • Seven studies with 4559 patients (2666 single-stent, 1933 two-stent) were included.
  • Pooled prevalence: HT 69.4%, HyperL 38.9%, DM 31%.
  • HT prevalence was lower in single-stent vs. two-stent (63% vs. 66.7%, P=0.01). HyperL and DM were more prevalent in single-stent vs. two-stent (41.6% vs. 34.1%, P<0.001 for HyperL; 32.5% vs. 31.8%, P=0.61 for DM).

Conclusions:

  • Hypertension, hyperlipidemia, and diabetes mellitus are frequent comorbidities in patients with LM bifurcation disease, regardless of stenting strategy.
  • Hypertension is the most prevalent risk factor in severe LM disease requiring a two-stent technique.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
65
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
71
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
89
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
441
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
91
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.2K